Gabriella Abruzzo
Climate Projects Officer, Health Care Without Harm Europe (HCWH)

Nathalie Moll graduated in Biochemistry and Biotechnology joint honours from St Andrews University, Scotland. As a biotechnologist, she has worked 30 years for the biotech & pharma industries at EU and national level in corporate and association positions.
She has been the Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA) since 2017, with EFPIA being named Best Trade Association in Brussels in 2022. Prior to that, she served 14 years at EuropaBio, lastly as Secretary General, during which time the association was ranked most effective trade association in Brussels in 2013.
Nathalie was also a founder and held the position of Vice Chair of the International Council of Biotech Associations (ICBA) before moving to EFPIA. Moll was named one of the 15 leading women in biotech in Europe in 2017, recognised as one of the "20 Women Who Shape Brussels" by POLITICO Europe in 2020 and Among the Women who advance associations in 2021.
Climate Projects Officer, Health Care Without Harm Europe (HCWH)
Capacity Building Officer & Patient Advocate, European Patients' Forum (EPF)
President, European Federation of Neurological Associations (EFNA)
President, Standing Committee of European Doctors (CPME)
Secretary General, European Alcohol Policy Alliance
President & CEO, The Ehlers-Danlos Society
Director of Preference Research and Global Lead of the Patient-Centered Outcomes, OPEN Health
MD, Board Member, European Patients' Forum (EPF)
Senior Manager IVD, MedTech Europe
Executive Director, European Regional and Local Health Authorities (EUREGHA)
Researcher & Populariser, Vaccination et Lien Social (VLS)
Senior Research Officer, Swedish Research Council
Chair, Council of Europe Steering Committee for Human Rights in the fields of Biomedicine and Health (CDBIO)
Executive Director, EUPATI
Movement Health, Executive Director
Deputy Administrator General, National Institute for Health and Disability Insurance (NIHDI)
President, European Patients' Forum (EPF)
Board Chair, Czech National Association of Patient Organizations (NAPO) & Board Member, European Patients' Forum (EPF)
Director for Executive Education in Government, Health and Non Profit Division, SDA Bocconi
Implementation Scientist & Qualitative Researcher, University of Antwerp
Policy Officer, DG SANTE, European Commission
Youth Group Member, European Patients' Forum (EPF)
President, European Liver Patient Association (ELPA)
Head of Government Affairs, EMEA MedTech, Johnson & Johnson
Professor, Sorbonne Université
Regional Director, WHO/Europe
Youth Group Member, European Patients' Forum (EPF)
Director for Digital, EU4Health and Health systems modernisation, DG SANTE, European Commission
Director General, EFPIA
IMMUcan scientific lead
Senior Economist, Organisation for Economic Co-operation and Development (OECD)
Executive Director, Biomed Alliance
SVP International, Butterfly Network Inc
Director General, AESGP
Vice President Corporate Affairs, Shionogi Europe
Public Affairs Director, OM Pharma
Chief Medical Officer, European Medicines Agency
Prof Dr, Erasmus University Rotterdam
Head of Unit, Policy and Coordination, HERA, European Commission
More speakers Announced soon
Stay Tuned!
CEO, Millwater Partners
Chief Partnership Officer, The Synergist
Regional Innovation Lead, NHS Greater Glasgow and Clyde Board (NHSGGC)
Policy Officer, European Patients' Forum (EPF)
PhD, MBA. Secretary of the Board, HTAi
Policy Officer, European Patients' Forum (EPF)
Head of Policy, European Patients' Forum (EPF)
Interim Executive Director, European Patients' Forum (EPF)
More moderators Announced soon
Stay Tuned!